Evidence map›Paper›PMID 30872611›Full record

ArticleScientific reports2019

Changes in the asymmetric distribution of cholesterol in the plasma membrane influence streptolysin O pore formation.

Fumihiko Ogasawara, Fumi Kano, Masayuki Murata, Yasuhisa Kimura, Noriyuki Kioka, Kazumitsu Ueda

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Pathways and Mechanisms of Cellular Cholesterol Efflux-Insight From Imaging.Frontiers in cell and developmental biology · 2022
    Review
  9. Article
  10. Review
  11. Review
  12. The Journal of biological chemistry · 2020
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Fumihiko OgasawaraGraduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.
Fumi KanoInstitute of Innovative Research, Tokyo Institute of Technology, Kanagawa, 226-8503, Japan.
Masayuki MurataGraduate School of Arts and Sciences, The University of Tokyo, Tokyo, 153-8902, Japan.
Yasuhisa KimuraGraduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.
Noriyuki KiokaGraduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.ORCID 0000-0002-2708-537X
Kazumitsu UedaGraduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan. uedak@kais.kyoto-u.ac.jp.ORCID 0000-0003-2980-6078
Kyoto University · JPTokyo Institute of Technology · JPTokyo University of the Arts · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ATP-binding cassette A1 (ABCA1) plays a key role in generating high-density lipoprotein (HDL) and preventing atherosclerosis. ABCA1 exports cholesterol and phospholipid to apolipoprotein A-I (apoA-I) in serum to generate HDL. We found that streptolysin O (SLO), a cholesterol-dependent pore-forming toxin, barely formed pores in ABCA1-expressing cells, even in the absence of apoA-I. Neither cholesterol content in cell membranes nor the amount of SLO bound to cells was affected by ABCA1. On the other hand, binding of the D4 domain of perfringolysin O (PFO) to ABCA1-expressing cells increased, suggesting that the amount of cholesterol in the outer leaflet of the plasma membrane (PM) increased and that the cholesterol dependences of these two toxins differ. Addition of cholesterol to the PM by the MβCD-cholesterol complex dramatically restored SLO pore formation in ABCA1-expressing cells. Therefore, exogenous expression of ABCA1 causes reduction in the cholesterol level in the inner leaflet, thereby suppressing SLO pore formation.

Indexed as

Apolipoprotein A-IATP Binding Cassette Transporter 1Bacterial ProteinsBacterial ToxinsCell MembraneCholesterolHEK293 CellsHemolysin ProteinsHumansLipoproteins, HDLStreptolysinsABCA1 protein, humanAPOA1 protein, humanApolipoprotein A-IATP Binding Cassette Transporter 1Bacterial ProteinsBacterial ToxinsCholesterolClostridium perfringens theta-toxinHemolysin ProteinsLipoproteins, HDLstreptolysin OStreptolysins

Identifiers

PMID30872611
PMCPMC6418215
OpenAlexW2921728569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.